William Ridgway Appointed Director of UC's Division of Immunology
William Ridgway, MD, has been appointed director of the division of immunology at the University of Cincinnati (UC)
Ridgway was previously an associate professor of medicine, with tenure, in the division of rheumatology and clinical immunology at the University of Pittsburgh School of Medicine where he researched the genetics and cellular immunology of autoimmunity. He focuses primarily on investigating mouse models with spontaneous autoimmune syndromes such as type 1 diabetes and autoimmune liver disease. He was also a principal investigator within the National Institutes of Health (NIH) funded Autoimmunity Center of Excellence at the
From 1998 to 2003, Ridgway served as chief of the rheumatology division at the
I am very excited to have Dr. Ridgway lead UCs division of immunology, says David Stern, MD, vice president for health affairs at UC and dean of the
He will be a welcome addition to the leadership team of the
Ridgway received his medical degree from the
He has collaborated with many physicians, nationally and internationally, on basic research, particularly in the areas of autoimmunity and autoimmune phenotypes. Additionally, Ridgway has retained repeated research support through grants from the NIH.
During his career, Ridgway has received several distinguished awards including the
highly competitive Pfizer Scholars Grant for new faculty and Juvenile Diabetes Foundation International Career Development Award. He is a member of the
I am pleased and honored to join the Division of Immunology at University of Cincinnati Academic Health Center, Ridgway says. I look forward to starting new research initiatives in lupus, allergy and the immunogenetics of autoimmune disease.
Ridgway replaces John Houk, MD, interim director of the immunology division.
Related Stories
UC radiation oncologist speaks with Local 12 news about clinical trial for head and neck cancer treatment
August 10, 2026
Dr. Sara Medek, a UC radiation oncology professor, speaks with Local 12 news about a new clinical trial aimed at reducing radiation in certain areas while still treating cancer effectively but with fewer painful side effects.
Cancer Center director charts future based on collaboration, AI
August 10, 2026
David Gius, MD, PhD, was featured in a Cincinnati Business Courier article and The Cancer Letter’s “The Directors" podcast discussing his priorities and goals as he recently took the helm as director of the University of Cincinnati Cancer Center.
UC graduates cross finish line at commencement
August 7, 2026
The University of Cincinnati recognized 2,125 graduates in two ceremonies at summer commencement Friday on campus at Fifth Third Arena.